Folding stability of amyloid‐β 40 monomer is an important determinant of the nucleation kinetics in fibrillization
暂无分享,去创建一个
Hui‐Ming Yu | Yun‐Chorng Chang | Chun-Lun Ni | Chun‐Lun Ni | Hoi‐Ping Shi | Hui‐Ming Yu | Yun‐Chorng Chang | and Yun‐Ru Chen | Hoi-Ping Shi | and Yun‐Ru Chen
[1] D. Teplow,et al. Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.
[2] V. Uversky,et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.
[3] Jun-tao Guo,et al. Molecular modeling of the core of Abeta amyloid fibrils. , 2004, Proteins.
[4] John Q Trojanowski,et al. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.
[5] A. Hofman,et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene , 1992, Nature Genetics.
[6] Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein. , 2008, Journal of molecular biology.
[7] P. Scheltens,et al. Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same? , 2005, Annals of neurology.
[8] Sheena E Radford,et al. The Yin and Yang of protein folding , 2005, The FEBS journal.
[9] A. Mark,et al. Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: A molecular dynamics study , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[11] D. Teplow,et al. On the nucleation of amyloid β‐protein monomer folding , 2005 .
[12] D. Selkoe,et al. Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin , 2008, Neurobiology of Disease.
[13] G. Weber,et al. Dimer formation from 1-amino-8-naphthalenesulfonate catalyzed by bovine serum albumin. A new fluorescent molecule with exceptional binding properties. , 1969, Biochemistry.
[14] J. Kelly,et al. Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] H. Levine. 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonate: report on non-β-sheet conformers of Alzheimer's peptide β(1-40) , 2002 .
[16] Jun-tao Guo,et al. Molecular modeling of the core of Aβ amyloid fibrils , 2004 .
[17] D. Teplow,et al. Familial Alzheimer's disease mutations alter the stability of the amyloid β-protein monomer folding nucleus , 2007, Proceedings of the National Academy of Sciences.
[18] D. Kirschner,et al. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] Ying Xu,et al. Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. , 2004, Journal of molecular biology.
[20] H. Levine. 4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40). , 2002, Archives of biochemistry and biophysics.
[21] R. Tycko,et al. Molecular structure of amyloid fibrils: insights from solid-state NMR , 2006, Quarterly Reviews of Biophysics.
[22] M. Howard,et al. Comparison of the effects of 2,2,2-trifluoroethanol on peptide and protein structure and function. , 2007, Journal of structural biology.
[23] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. W. Bolen,et al. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.
[25] D. Teplow,et al. On the nucleation of amyloid beta-protein monomer folding. , 2005, Protein science : a publication of the Protein Society.
[26] R. Roos,et al. Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type (HCHWA‐D): I ‐ A Review of Clinical, Radiologic and Genetic Aspects , 1996, Brain pathology.
[27] C. Cotman,et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.
[28] R. Riek,et al. NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox). , 2001, European journal of biochemistry.
[29] D. Selkoe,et al. Deciphering the genetic basis of Alzheimer's disease. , 2002, Annual review of genomics and human genetics.
[30] J. Brewer,et al. Solution NMR Studies of the Aβ(1−40) and Aβ(1−42) Peptides Establish that the Met35 Oxidation State Affects the Mechanism of Amyloid Formation , 2004 .
[31] D Thirumalai,et al. Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions. , 2008, Journal of molecular biology.
[32] P. A. Evans,et al. Kinetics of interaction of partially folded proteins with a hydrophobic dye: Evidence that molten globule character is maximal in early folding intermediates , 1995, Protein science : a publication of the Protein Society.
[33] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[34] Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.
[35] L. Juliano,et al. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. , 2005, The Journal of biological chemistry.
[36] Carl Frieden. Protein aggregation processes: In search of the mechanism , 2007, Protein science : a publication of the Protein Society.
[37] D. Teplow,et al. Amyloid β-Protein Assembly and Alzheimer Disease* , 2009, Journal of Biological Chemistry.
[38] R. Tycko,et al. Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. , 2005, Biochemistry.
[39] D. Teplow,et al. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. , 2002, The Journal of biological chemistry.
[40] B. Strooper,et al. In Vitro Studies of Flemish, Dutch, and Wild-Type β-Amyloid Provide Evidence for Two-Staged Neurotoxicity , 2002, Neurobiology of Disease.
[41] S. Younkin,et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.
[42] H. Weiner,et al. Immunology and immunotherapy of Alzheimer's disease , 2006, Nature Reviews Immunology.
[43] R. Tycko,et al. Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. , 2009, Biochemistry.
[44] I. Lieberburg,et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.
[45] Yun-Ru Chen,et al. Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. , 2006, The Journal of biological chemistry.
[46] T. Grabowski,et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.
[47] Yun-Ru Chen,et al. Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42 , 2006, Journal of Biological Chemistry.
[48] P. Scheltens,et al. Amyloid β 38, 40, and 42 species in cerebrospinal fluid: More of the same? , 2005 .
[49] Ralf Langen,et al. Structural and Dynamic Features of Alzheimer's Aβ Peptide in Amyloid Fibrils Studied by Site-directed Spin Labeling* , 2002, The Journal of Biological Chemistry.
[50] J. Hardy,et al. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). , 1990, Science.
[51] J. Brewer,et al. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. , 2004, Journal of the American Chemical Society.
[52] C. van Broeckhoven,et al. Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. , 1998, Neurobiology of disease.
[53] Yue-Ming Li,et al. An APP inhibitory domain containing the Flemish mutation residue modulates γ-secretase activity for Aβ production , 2010, Nature Structural &Molecular Biology.
[54] Ulrich Baxa,et al. β arcades: recurring motifs in naturally occurring and disease‐related amyloid fibrils , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] Johannes Kornhuber,et al. Blood‐based neurochemical diagnosis of vascular dementia: a pilot study , 2007, Journal of neurochemistry.
[56] D. Teplow,et al. Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences. , 2008, Journal of molecular biology.
[57] G. Weber,et al. Dimer formation from 1-anilino-8-naphthalenesulfonate catalyzed by bovine serum albumin. Fluorescent molecule with exceptional binding properties , 1969 .
[58] L. Brand,et al. Fluorescence probes for structure. , 1972, Annual review of biochemistry.
[59] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[60] E. Wijsman,et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. , 1992, American journal of human genetics.
[61] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.